Pharmacokinetics/Pharmacodynamics
Med. 2015;192(11):1298-1305. https://doi.org/10.1164/
rccm.201505-0857oc
Fernandez C, Buyse M, German-Fattal M, Gimenez
F. Influence of the pro-inflammatory cytokines on
P-glycoprotein expression and functionality. J Pharm
Pharm Sci. 2004;7(3):359-371. http://www.ualberta.
ca/~csps/JPPS7(3)/F.Gimenez/P-gp.htm
Forrest A, Nix DE, Ballow CH, Goss TF, Birmingham
MC, Schentag JJ. Pharmacodynamics of intravenous
ciprofloxacin in seriously ill patients. Antimicrob
Agents Chemother. 1993;37(5):1073-1081. https://doi.
org/10.1128/aac.37.5.1073
Fuchs A, Csajka C, Thoma Y, Buclin T, Widmer N.
Benchmarking therapeutic drug monitoring soft-
ware: a review of available computer tools. Clin
Pharmacokinet. 2013;52(1):9-22. https://doi.org/10.1007/
s40262-012-0020-y
Fuster-Lluch
O,
Gerónimo-Pardo
M,
Peyró-García R, Lizán-García M. Glomerular hyper-
filtration and albuminuria in critically ill patients.
org/10.1177/0310057x0803600507
Garrelts JC, Jost G, Kowalsky SF, Krol GJ, Lettieri
JT. Ciprofloxacin pharmacokinetics in burn patients.
Antimicrob Agents Chemother. 1996;40(5):1153-1156.
https://doi.org/10.1128/aac.40.5.1153
Goldberger ZD, Goldberger AL. Therapeutic ranges of
serum digoxin concentrations in patients with heart fail-
org/10.1016/j.amjcard.2012.02.028
Gonçalves-Pereira J, Póvoa P. Antibiotics in critically
ill patients: a systematic review of the pharmacokinet-
org/10.1186/cc10441
Grissinger M. Preventing errors when drugs are given
via enteral feeding tubes. P T. 2013;38(10):575-576.
https://pmc.ncbi.nlm.nih.gov/articles/pmid/24391375/
Gump FE, Price JB Jr, Kinney JM. Whole body
and splanchnic blood flow and oxygen consump-
tion measurements in patients with intraperitoneal
org/10.1097/00000658-197003000-00001
Hamilton LA, Christopher Wood G, Magnotti LJ, et
al. Treatment of methicillin-resistant Staphylococcus
aureus ventilator-associated pneumonia with high-
dose vancomycin or linezolid. J Trauma Acute Care
Surg.
2012;72(6):1478-1483.
https://doi.org/10.1097/
ta.0b013e318250911b
Hanrahan TP, Harlow G, Hutchinson J, et al.
Vancomycin-associated nephrotoxicity in the criti-
cally ill: a retrospective multivariate regression
doi.org/10.1097/ccm.0000000000000514
Heming N, Faisy C, Urien S. Population pharmacody-
namic model of bicarbonate response to acetazolamide
in mechanically ventilated chronic obstructive pulmo-
doi.org/10.1186/cc10448
Hernandez G, Velasco N, Wainstein C, et al. Gut mucosal
atrophy after a short enteral fasting period in critically
org/10.1016/s0883-9441(99)90017-5
Hinshaw LB, Beller BK, Chang AC, et al. Evaluation of
naloxone for therapy of Escherichia coli shock. Species
differences. Arch Surg. 1984;119(12):1410-1418. https://
doi.org/10.1001/archsurg.1984.01390240048009
Hodiamont CJ, Janssen JM, de Jong MD, Mathôt RA,
Juffermans NP, van Hest RM. Therapeutic drug moni-
toring of gentamicin peak concentrations in critically ill
patients. Ther Drug Monit. 2017;39(5):522-530. https://
doi.org/10.1097/ftd.0000000000000432
Holley FO, Ponganis KV, Stanski DR. Effects of car-
diac surgery with cardiopulmonary bypass on lidocaine
disposition. Clin Pharmacol Ther. 1984;35(5):617-626.
https://doi.org/10.1038/clpt.1984.85
Iida Y, Nishi S, Asada A. Effect of mild therapeu-
tic hypothermia on phenytoin pharmacokinetics.
Ther Drug Monit. 2001;23(3):192-197. https://doi.
org/10.1097/00007691-200106000-00002
Jardin F, Farcot JC, Boisante L, Curien N, Margairaz
A, Bourdarias JP. Influence of positive end-expira-
tory pressure on left ventricular performance. N Engl
J Med. 1981;304(7):387-392. https://doi.org/10.1056/
nejm198102123040703
Jenkins A, Thomson AH, Brown NM, et al. Amikacin
use and therapeutic drug monitoring in adults: do dose
regimens and drug exposures affect either outcome
or adverse events? A systematic review. J Antimicrob
Chemother.
2016;71(10):2754-2759.
https://doi.
org/10.1093/jac/dkw250